Adaptive Biotechnologies Corporation (ADPT)
USD 9.84
(33.7%)
USD 9.84
(33.7%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 229.43 Million USD | 112.43% |
| 2022 | 108 Million USD | -3.35% |
| 2021 | 111.74 Million USD | 3.6% |
| 2020 | 107.86 Million USD | 194.65% |
| 2019 | 36.6 Million USD | -93.48% |
| 2018 | 561.19 Million USD | -0.09% |
| 2017 | 561.67 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 226.25 Million USD | 134.48% |
| 2024 Q1 | 96.49 Million USD | -57.94% |
| 2023 Q2 | 103.52 Million USD | -2.14% |
| 2023 FY | 229.43 Million USD | 112.43% |
| 2023 Q4 | 229.43 Million USD | 126.47% |
| 2023 Q3 | 101.3 Million USD | -2.14% |
| 2023 Q1 | 105.78 Million USD | -2.06% |
| 2022 Q4 | 108 Million USD | -0.96% |
| 2022 Q2 | 111.34 Million USD | -1.92% |
| 2022 FY | 108 Million USD | -3.35% |
| 2022 Q1 | 113.52 Million USD | 1.6% |
| 2022 Q3 | 109.04 Million USD | -2.06% |
| 2021 Q1 | 99.56 Million USD | -7.7% |
| 2021 Q2 | 108.6 Million USD | 9.09% |
| 2021 Q3 | 113.15 Million USD | 4.18% |
| 2021 Q4 | 111.74 Million USD | -1.25% |
| 2021 FY | 111.74 Million USD | 3.6% |
| 2020 Q2 | 45.73 Million USD | 20.2% |
| 2020 Q4 | 107.86 Million USD | 132.79% |
| 2020 Q3 | 46.33 Million USD | 1.32% |
| 2020 Q1 | 38.04 Million USD | 3.93% |
| 2020 FY | 107.86 Million USD | 194.65% |
| 2019 Q4 | 36.6 Million USD | 56.11% |
| 2019 FY | 36.6 Million USD | -93.48% |
| 2019 Q3 | 23.44 Million USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | 561.19 Million USD | -0.09% |
| 2017 FY | 561.67 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Absci Corporation | 15.95 Million USD | -1337.814% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 91.447% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -76195.749% |
| Apollomics, Inc. | 4.66 Million USD | -4822.377% |
| 180 Life Sciences Corp. | 1.32 Million USD | -17280.304% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 44.95 Million USD | -410.348% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -1668.126% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -126.3% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -980.239% |
| Chimerix, Inc. | 2.14 Million USD | -10601.119% |
| CRISPR Therapeutics AG | 238.63 Million USD | 3.855% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -18.759% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -4095.136% |
| Fortress Biotech, Inc. | 88.59 Million USD | -158.976% |
| Fortress Biotech, Inc. | 88.59 Million USD | -158.976% |
| Gritstone bio, Inc. | 104.77 Million USD | -118.976% |
| Allakos Inc. | 41.46 Million USD | -453.315% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -10352.483% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -431.499% |
| Cytokinetics, Incorporated | 755.77 Million USD | 69.643% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -2246.41% |
| Innoviva, Inc. | 449.07 Million USD | 48.91% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -415801.387% |
| NLS Pharmaceutics AG | 1.63 Million USD | -13943.309% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -3222.213% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -79111.995% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -37948.425% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1556.549% |
| ImmuCell Corporation | 11.96 Million USD | -1816.837% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -7888.579% |
| Incyte Corporation | 38.28 Million USD | -499.243% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -659.476% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -139825.717% |
| Mustang Bio, Inc. | 2.49 Million USD | -9084.628% |
| MiMedx Group, Inc. | 48.09 Million USD | -377.0% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 33.97 Million USD | -575.376% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 5.95 Million USD | -3754.704% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -107.898% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 62.448% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -179.738% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -112920.69% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -161471.831% |
| NextCure, Inc. | 6.6 Million USD | -3373.611% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -13500.0% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 9.88 Million USD | -2220.83% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -72048.428% |
| Opthea Limited | 200.62 Million USD | -14.356% |
| Ovid Therapeutics Inc. | 46 Million USD | -398.747% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -2896.214% |
| PDS Biotechnology Corporation | 23.85 Million USD | -861.914% |
| Precigen, Inc. | 7.09 Million USD | -3132.803% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -1582.916% |
| PureTech Health plc | 25.51 Million USD | -799.31% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -816.189% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 91.512% |
| Replimune Group, Inc. | 75.86 Million USD | -202.405% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -278.732% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -50820.277% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -160.884% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -502.121% |
| Solid Biosciences Inc. | 26.26 Million USD | -773.528% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -13932.538% |
| SciSparc Ltd. | 76 Thousand USD | -301784.211% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -25.545% |
| TG Therapeutics, Inc. | 110.79 Million USD | -107.078% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -2238.041% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -40507.434% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 43.32% |
| UroGen Pharma Ltd. | 100.21 Million USD | -128.942% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -404.135% |
| XOMA Corporation | 124.45 Million USD | -84.357% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -401.239% |
| AbCellera Biologics Inc. | 77.38 Million USD | -196.5% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -48201.474% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -998.59% |
| Precision BioSciences, Inc. | 31.26 Million USD | -633.76% |
| Dyadic International, Inc. | 136.92 Thousand USD | -167455.448% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -145110.127% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -4105.903% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -107111.215% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -1746.684% |
| IGM Biosciences, Inc. | 40.5 Million USD | -466.415% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -293.665% |
| Acelyrin, Inc. | 1.19 Million USD | -19115.41% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -4148.741% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -3621.525% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -36785.996% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -659.306% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -269.605% |
| Senti Biosciences, Inc. | 37.66 Million USD | -509.122% |
| Mesoblast Limited | 118.92 Million USD | -92.925% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -170.959% |
| ChromaDex Corporation | 3.27 Million USD | -6901.282% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -120.222% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -711.89% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -0.105% |
| Novavax, Inc. | 280.63 Million USD | 18.245% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -121.596% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -263.215% |
| Celcuity Inc. | 37.44 Million USD | -512.696% |
| ContextLogic Inc. | 6 Million USD | -3723.867% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -65.023% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -3397.972% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 96.042% |
| Amarin Corporation plc | 8.73 Million USD | -2525.981% |
| AnaptysBio, Inc. | 17.81 Million USD | -1187.931% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -4151.102% |
| Aptorum Group Limited | 3.36 Million USD | -6723.466% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1994.313% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -99.21% |
| Ardelyx, Inc. | 55.98 Million USD | -309.832% |
| Celularity Inc. | 65.41 Million USD | -250.722% |
| Omeros Corporation | 338.28 Million USD | 32.177% |
| Humacyte, Inc. | 58.1 Million USD | -294.851% |
| Immunocore Holdings plc | 84.03 Million USD | -173.029% |
| IO Biotech, Inc. | 2.49 Million USD | -9099.358% |
| GT Biopharma, Inc. | 58 Thousand USD | -395472.414% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -4472.18% |
| Summit Therapeutics Inc. | 106.09 Million USD | -116.243% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 8.75 Million USD | -2520.283% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -98.908% |
| Evogene Ltd. | 1.13 Million USD | -20060.984% |
| CorMedix Inc. | 667.63 Thousand USD | -34265.039% |
| BioLineRx Ltd. | 11.59 Million USD | -1879.398% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -10722.264% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -352872.308% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 44.719% |
| scPharmaceuticals Inc. | 40.26 Million USD | -469.748% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -2020.248% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -151841.722% |
| NLS Pharmaceutics AG | 1.63 Million USD | -13943.309% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -780.974% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -65639.828% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -75123.607% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -3256.723% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -23479.856% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -545.283% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 5.31 Million USD | -4214.136% |
| bluebird bio, Inc. | 330.32 Million USD | 30.544% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 79.766% |
| DBV Technologies S.A. | 14.38 Million USD | -1495.383% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -2228.786% |
| Galecto, Inc. | 249 Thousand USD | -92041.365% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -3595.747% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -4877.913% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -9.18% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -28280.929% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -11.42% |
| ADMA Biologics, Inc. | 141.41 Million USD | -62.237% |
| Clene Inc. | 32.16 Million USD | -613.386% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -352.779% |
| Aptose Biosciences Inc. | 1 Million USD | -22620.404% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -2650454.529% |
| Soligenix, Inc. | 3.49 Million USD | -6465.403% |
| Century Therapeutics, Inc. | 48.17 Million USD | -376.287% |
| Kura Oncology, Inc. | 17.2 Million USD | -1233.907% |
| Surrozen, Inc. | 3.37 Million USD | -6689.938% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -148.214% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -10571.256% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1541.849% |
| Autolus Therapeutics plc | 52.96 Million USD | -333.16% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -448.316% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -734.754% |
| GRI Bio, Inc. | 14 Thousand USD | -1638700.0% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -834.855% |
| INmune Bio, Inc. | 10.43 Million USD | -2098.256% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -27.726% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3784.031% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -280791.283% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -45703.679% |
| Jaguar Health, Inc. | 35.86 Million USD | -539.799% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -27647.919% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -343.133% |
| Clearside Biomedical, Inc. | 43 Million USD | -433.55% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -296.447% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 52.285% |
| Verastem, Inc. | 41.55 Million USD | -452.09% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -1917.517% |
| Histogen Inc. | 4.62 Million USD | -4863.912% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -301.07% |
| Surrozen, Inc. | 3.37 Million USD | -6689.938% |
| Organovo Holdings, Inc. | 1.39 Million USD | -16358.537% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1074522.951% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -171.235% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -109665.573% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -141248.103% |
| Kronos Bio, Inc. | 28.27 Million USD | -711.517% |
| Turnstone Biologics Corp. | 3.21 Million USD | -7038.519% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -92787.449% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -236.263% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -135.057% |
| Exelixis, Inc. | 189.94 Million USD | -20.789% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -649.435% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -106.83% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -8135.176% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -285518.962% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -469374.115% |
| Avid Bioservices, Inc. | 207.83 Million USD | -10.392% |
| Insmed Incorporated | 1.2 Billion USD | 80.944% |
| MediWound Ltd. | 6.71 Million USD | -3318.745% |
| OmniAb, Inc. | 25.56 Million USD | -797.586% |
| Alector, Inc. | 38.91 Million USD | -489.527% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -7.243% |
| Zai Lab Limited | 15.15 Million USD | -1414.303% |
| AlloVir, Inc. | 27.42 Million USD | -736.458% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 52.045% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -2146.47% |
| Aura Biosciences, Inc. | 19.55 Million USD | -1073.145% |
| Immunic, Inc. | 1.33 Million USD | -17098.801% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -623.03% |
| Veracyte, Inc. | 12.63 Million USD | -1716.564% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 64.422% |
| FibroGen, Inc. | 170.45 Million USD | -34.6% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2426.506% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -6350.155% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -112415.754% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -619986.486% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -5314.963% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 86.327% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -3035.602% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -8135.176% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1488.424% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -25223.62% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -753.51% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -409.023% |
| Agenus Inc. | 350.24 Million USD | 34.494% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -16068.569% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -407.189% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -431.474% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -375.714% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 72.967% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -22231.365% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -223.253% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -1616301.296% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -58428.273% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -97750.907% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -59803.916% |
| Ainos, Inc. | 5.96 Million USD | -3747.235% |
| Pluri Inc. | 29.61 Million USD | -674.794% |
| Prothena Corporation plc | 11.83 Million USD | -1838.589% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -809.182% |
| Rallybio Corporation | 392 Thousand USD | -58428.571% |
| Kodiak Sciences Inc. | 181.63 Million USD | -26.317% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1461.293% |
| MeiraGTx Holdings plc | 89.26 Million USD | -157.026% |
| Annexon, Inc. | 31.35 Million USD | -631.724% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -9696.413% |
| Moderna, Inc. | - USD | -Infinity% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -12281.651% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -4604.367% |
| Blueprint Medicines Corporation | 774.12 Million USD | 70.362% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -398.343% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -271.141% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -614.341% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -120.404% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -3216.929% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -627.247% |
| Nutriband Inc. | 241.28 Thousand USD | -94987.552% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -4096.671% |
| Vor Biopharma Inc. | 35.66 Million USD | -543.388% |
| Roivant Sciences Ltd. | 499.74 Million USD | 54.091% |
| Alkermes plc | 290.73 Million USD | 21.084% |
| ProKidney Corp. | 4.41 Million USD | -5099.003% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -18613.866% |
| Arcellx, Inc. | 97.62 Million USD | -135.014% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 86.813% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -489.496% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -219.512% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1292.522% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -9260.766% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -33889.926% |
| MediciNova, Inc. | 215.92 Thousand USD | -106154.921% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -9095.671% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -18094.045% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -23.104% |
| Biomea Fusion, Inc. | 10.29 Million USD | -2128.361% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -6290.864% |
| Geron Corporation | 85.89 Million USD | -167.095% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2404.443% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1463.847% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -736.885% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -1771.692% |
| Royalty Pharma plc | 6.13 Billion USD | 96.26% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -1734.575% |
| Imunon, Inc. | 1.62 Million USD | -14021.378% |
| BioAtla, Inc. | 2.46 Million USD | -9226.504% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -141.2% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -4036.891% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -578.191% |
| Structure Therapeutics Inc. | 5.45 Million USD | -4107.445% |
| 89bio, Inc. | 27.1 Million USD | -746.363% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1111.81% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1419.921% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1959.903% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -990.042% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -70171.644% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -13960.703% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 84.697% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -116.315% |
| Liquidia Corporation | 3.5 Million USD | -6449.586% |
| Entera Bio Ltd. | 390 Thousand USD | -58728.718% |
| GH Research PLC | 343 Thousand USD | -66789.796% |
| Vericel Corporation | 88.14 Million USD | -160.295% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -2530.799% |
| Xencor, Inc. | 83.43 Million USD | -174.986% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -132770.802% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -280791.283% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -18640.984% |
| Vaxcyte, Inc. | 29.22 Million USD | -685.081% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -2004.302% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -2339.728% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -139825.717% |
| Portage Biotech Inc. | 47 Thousand USD | -488053.191% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -18094.045% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -9392.429% |
| OncoCyte Corporation | 2.86 Million USD | -7896.933% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -17559.265% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -152291.833% |
| Purple Biotech Ltd. | 351 Thousand USD | -65265.242% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1010.459% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -13779.734% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -18108.889% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -7162.805% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -39870.732% |
| United Therapeutics Corporation | 700 Million USD | 67.224% |
| HilleVax, Inc. | 51.19 Million USD | -348.171% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -227060.396% |
| Pharming Group N.V. | 171.54 Million USD | -33.744% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -11179.848% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -4286.006% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -975.58% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -758.075% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1263.232% |
| Curis, Inc. | 2.79 Million USD | -8111.596% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -10638.941% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1271.299% |
| BeiGene, Ltd. | 930.18 Million USD | 75.335% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -20007.975% |
| Erasca, Inc. | 55.85 Million USD | -310.734% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -9069.944% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -4840.396% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -8925.649% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1116.952% |
| Adicet Bio, Inc. | 20.92 Million USD | -996.502% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 48.449% |
| Aditxt, Inc. | 18.21 Million USD | -1159.371% |
| Adagene Inc. | 22.3 Million USD | -928.526% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1399.262% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1030.597% |
| Compugen Ltd. | 1.35 Million USD | -16882.383% |
| Generation Bio Co. | 97.89 Million USD | -134.368% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -69636.17% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -806.918% |
| Invivyd, Inc. | 2.16 Million USD | -10497.321% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -329.118% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -6510955.047% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -4039.13% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -364077.778% |
| 2seventy bio, Inc. | 256.67 Million USD | 10.613% |
| Instil Bio, Inc. | 86.05 Million USD | -166.614% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -3988.127% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -108899.52% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -47574.677% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1234.14% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -84.224% |
| Evaxion Biotech A/S | 10.86 Million USD | -2010.752% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -175.135% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -206.289% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -3431.897% |
| Cingulate Inc. | 3.13 Million USD | -7218.174% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -559490.244% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -750.063% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -49240.215% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1034.735% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -14654.469% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -18108.889% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -95.773% |
| ImmunityBio, Inc. | 883.67 Million USD | 74.037% |
| Korro Bio, Inc. | 33.2 Million USD | -590.915% |
| Kineta, Inc. | 1.31 Million USD | -17320.805% |
| BioVie Inc. | 6.11 Million USD | -3654.135% |
| Codexis, Inc. | 22.36 Million USD | -925.899% |
| Celularity Inc. | 65.41 Million USD | -250.722% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -150.861% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -343.535% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -102188.007% |
| Cibus, Inc. | 24.62 Million USD | -831.855% |
| IN8bio, Inc. | 4.89 Million USD | -4588.984% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -205.763% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -5778.35% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 84.216% |
| Eyenovia, Inc. | 16.1 Million USD | -1324.357% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -105.787% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -23192.589% |
| Elevation Oncology, Inc. | 30.13 Million USD | -661.297% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1902.549% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -10576.221% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -765.357% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -7296.26% |
| Moolec Science SA | 2.64 Million USD | -8573.23% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -705.392% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -3534.278% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -9451.707% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -13139.008% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -198966.41% |
| Humacyte, Inc. | 58.1 Million USD | -294.851% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -1626.87% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -9008.059% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -17047.384% |
| Notable Labs, Ltd. | 2.04 Million USD | -11097.267% |
| Immunovant, Inc. | 138 Thousand USD | -166155.072% |
| Quantum-Si incorporated | 15.3 Million USD | -1399.262% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -57258.0% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -327.184% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -56831.017% |
| PepGen Inc. | 20.1 Million USD | -1041.226% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -5040.805% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -25795.26% |
| XOMA Corporation | 124.45 Million USD | -84.357% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -83634.307% |
| Bionomics Limited | 239.61 Million USD | 4.251% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1628.171% |
| uniQure N.V. | 138.4 Million USD | -65.764% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -168.583% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -22131.783% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -23192.589% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2426.506% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -13032.914% |
| Altimmune, Inc. | 671 Thousand USD | -34092.548% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -63279.006% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1628.171% |
| Peak Bio, Inc. | 10.72 Million USD | -2039.863% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -436.482% |
| Benitec Biopharma Inc. | 284 Thousand USD | -80685.915% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -171.341% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -1051.709% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -1847.805% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -1051.709% |
| argenx SE | 20 Million USD | -1047.16% |
| Immunome, Inc. | 1.65 Million USD | -13804.97% |
| Verona Pharma plc | 51.32 Million USD | -346.983% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -2246.41% |
| Shattuck Labs, Inc. | 4.2 Million USD | -5360.067% |
| CervoMed Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -5387.491% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -39119.145% |
| Moolec Science SA | 2.64 Million USD | -8573.23% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 3.05 Million USD | -7422.361% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -87469.466% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1512.539% |
| Achilles Therapeutics plc | 4.61 Million USD | -4871.441% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -14654.469% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -27676.271% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 38.609% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -662.258% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -6104.443% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -55184.819% |
| Beam Therapeutics Inc. | 173.17 Million USD | -32.487% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 25.543% |
| AEON Biopharma, Inc. | 278 Thousand USD | -82429.496% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -3166.401% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -68387.164% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -214541.083% |
| NeurAxis, Inc. | 224.26 Thousand USD | -102206.252% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -202.433% |
| Lumos Pharma, Inc. | 6.58 Million USD | -3384.161% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1243.269% |
| Palisade Bio, Inc. | 369 Thousand USD | -62076.694% |
| Nutriband Inc. | 241.28 Thousand USD | -94987.552% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -275.459% |
| Neurogene Inc. | 16.25 Million USD | -1311.455% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -703.868% |
| Athira Pharma, Inc. | 1.58 Million USD | -14375.205% |
| HCW Biologics Inc. | 6.45 Million USD | -3456.106% |
| XOMA Corporation | 124.45 Million USD | -84.357% |
| Nektar Therapeutics | 230.4 Million USD | 0.421% |
| Arvinas, Inc. | 3.4 Million USD | -6648.0% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -13960.703% |
| Merus N.V. | 12.16 Million USD | -1786.466% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -78.646% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -1560.866% |
| Rezolute, Inc. | 2.22 Million USD | -10197.666% |
| Clene Inc. | 32.16 Million USD | -613.386% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -130964.306% |
| BeyondSpring Inc. | 3.99 Million USD | -5642.979% |
| Synlogic, Inc. | 17.27 Million USD | -1228.116% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -17548.615% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -655420.0% |
| Peak Bio, Inc. | 10.72 Million USD | -2039.863% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -341.87% |
| Krystal Biotech, Inc. | 8.09 Million USD | -2734.594% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -29.611% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -3151.127% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -167866.382% |
| MannKind Corporation | 382.37 Million USD | 39.999% |
| Ikena Oncology, Inc. | 10.73 Million USD | -2036.636% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -55995.844% |
| Gossamer Bio, Inc. | 212.46 Million USD | -7.986% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -131757.471% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2404.443% |
| Legend Biotech Corporation | 328.67 Million USD | 30.194% |
| Mural Oncology plc | 15 Million USD | -1428.629% |
| Disc Medicine, Inc. | 2.1 Million USD | -10820.133% |
| Champions Oncology, Inc. | 7.43 Million USD | -2987.914% |
| REGENXBIO Inc. | 89.29 Million USD | -156.952% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -26743.665% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -41389.958% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -4137.754% |
| Vaxart, Inc. | 26.51 Million USD | -765.324% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1365.33% |
| Cellectis S.A. | 92.85 Million USD | -147.092% |
| Longeveron Inc. | 2.04 Million USD | -11141.156% |
| Repare Therapeutics Inc. | 3.41 Million USD | -6628.211% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 83.575% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -392.428% |
| Revolution Medicines, Inc. | 87.94 Million USD | -160.884% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -132519.653% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -5703.997% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -72276.025% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -131004.0% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 71.619% |
| Denali Therapeutics Inc. | 52.24 Million USD | -339.18% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1492.674% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -16598.108% |
| Cingulate Inc. | 3.13 Million USD | -7218.174% |
| Passage Bio, Inc. | 26.29 Million USD | -772.564% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -3342.341% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -56133.333% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -25563.535% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1015.86% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -9260.289% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -7246.526% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -28190.012% |
| OmniAb, Inc. | 25.56 Million USD | -797.586% |
| Anew Medical, Inc. | 1.6 Million USD | -14194.829% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -675.557% |
| Lipocine Inc. | 17.16 Thousand USD | -1336448.992% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1871.404% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -562.562% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3784.031% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -301.294% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -112920.69% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -4342.052% |
| Ocugen, Inc. | 6.94 Million USD | -3205.46% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1523.837% |
| Q32 Bio Inc. | 1.31 Million USD | -17307.587% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -34041.667% |
| Alumis Inc. Common Stock | 32.58 Million USD | -604.211% |
| Equillium, Inc. | 824 Thousand USD | -27743.689% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -2427.062% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -76172.415% |
| Dominari Holdings Inc. | 3.02 Million USD | -7477.015% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -242718.589% |
| vTv Therapeutics Inc. | 529 Thousand USD | -43270.888% |
| Bio-Techne Corporation | 419.53 Million USD | 45.313% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -218.673% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -18.529% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1258.55% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -907.961% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -3687.257% |
| Nkarta, Inc. | 88.33 Million USD | -159.718% |
| BioCardia, Inc. | 1.31 Million USD | -17347.3% |
| Iterum Therapeutics plc | 19.5 Million USD | -1076.032% |